The Last Untapped Market Event

  • -
Last Untapped Market event

The Last Untapped Market Event

Family Office Networks and ABS are holding a talk at Flemings Steakhouse in Newport Beach.  Charles Laverty will be speaking at this event titled The Last Untapped Market.

The discussion will be about how ABS platform is the only platform that covers all stenting.


  • -

Family Office Networks Partners With ABS

FON Says The ABS Platform Will Become The “standard of care”

Family Office Networks announced today a partnership with Advanced Bifurcation Systems (ABS) to introduce its family office members to the ABS platform. Calling our platform a “paradigm shift” in interventional cardiology and saying they expect the ABS platform to become the “standard of care” in the $2.5 billion global bifurcation market.

“ABS represents a great opportunity for family office investors who seek to make a real impact on the future of healthcare. We believe ABS is poised to capture a significant part of this $2.5B market as the only true and complete bifurcating stent delivery platform in the market”

Family Office Networks Founder Andrew Schneider.

 


  • -
New Heart Technologies in Battle post by Charles Laverty for ABS

Innovative Technologies Fight the World’s Top Killer

Technologies In Battle

Heart disease can strike when least expected. Almost everyone knows someone who has suffered from a heart attack or a stroke. At present, heart disease is still the number one killer in the world. But new technologies hold promise and are likely to revolutionize healthcare.

Mobile health technology is being seen as an affordable way to address risks associated with heart disease such as high blood pressure and excess weight. Studies have shown how patients responded to text messages of advice, support, and motivation, managing to meet their targets faster than control groups.

There is even a smartphone app that is able to measure how much blood the heart pumps with each beat. It can do this as well as an ultrasound.

Analyzing The Eye

Google scientists have found a way to assess the risk of heart disease by using machine learning. They have software that can analyze the back of a patient’s eye and establish the likelihood of a person suffering a cardiac event. This is not being used in clinical settings yet because further research is needed.

The NHS is planning to start using AI to diagnose scans this year. An AI system was developed at John Radcliffe Hospital that makes a possible more accurate diagnosis of scans.

With AI comes the ability to accumulate and analyze great quantities of medical data and improve on existing diagnostic procedures. In turn, patients benefit from receiving the right treatment at the right time which can improve their outlook.

A Simple Day Procedure

Our own dual catheter system has the potential to transform the way bifurcate lesions are treated, turning this into a simple day procedure rather than a complex, risky operation. Once again, the patient will benefit from less downtime and see better results.

The use of these new technologies could have a powerful impact on our lives, increasing life expectancy and reducing heart disease fatalities. They could mean the difference between life and death.


  • -
Charlie Laverty and Axcessnews

Raising Further Funds Story With Charlie Laverty by Axcessnews

Melissa Thompson of Axcessnews.com did a story with our CEO Charlie Laverty on how we are raising more funds for our company.  These funds will in turn, be life saving for a lot of people.

You can read the full article here.


  • -
RESI Toronto Innovation Challenge post by Charles Laverty

A Finalist RESI Toronto Innovation Challenge

Been Chosen

Our company is very happy to have been chosen as one of the finalist in this years RESI Toronto Innovation Challenge.

RESI Toronto Innovation Challenge

RESI handpicks businesses that exemplify important sections of the healthcare industry.  This includes diagnostics and digital health, therapeutics and medical devices.  Companies are picked for their technical merit and scientific merit as well as their commercial growth and activity.

RESI website found here.

 


  • -
Tech To Manage Heart Disease

New Tech Helps Manage Heart Disease

New Technology to Help with Health

You see a lot of people wearing pieces of technology to help them stay fit.  In staying fit, this in turn, helps people manage heart disease.

Manage Heart Disease Daily

From Fitbits and Garmins to phone apps, these are just a part of the new technology to help people.  We have created a new stent system that is helping people tremendously with their heart disease.

Our CEO, Charles Laverty, wrote about this topic for Newswire and you can find the article here.


  • -
Charles Laverty Interview for Inspirery post by ABS

Charles Laverty New Interview

Our CEO

Charles Laverty is our Chief Executive Officer here at Advanced Bifurcation Systems.  We are proud to promote his recent interview on Inspirery.com.

Charles is an important member of our company and is driving on a path with already proven successes.  You can check out his interview here.


  • -
Asian Market Strategic Move post by Charles Laverty CEO

Asian Market Sees The Potential

ABS is Making Noise in Asia

We’ve recently begun the next phase of our ongoing growth strategy that will focus on developing plans for the Asian market.  CEO Charles Laverty kicked off this next phase with his recent trip to China.  He met with both medical experts and potential investment partners. The trip was a major success.

Cardiovascular illness is the leading cause of death globally and nowhere is this more evident than in Asia. The Western world had long been considered to have the highest incidents of death from heart disease, but that’s simply no longer true.

1 Out Of 5

In China 1 out of every 5 adults has some form of cardiovascular related illness and those numbers are climbing. It’s part of the global pandemic that’s cutting far too many lives short long before their time. A combination of lifestyle changes and improved medical treatments are needed to curve this problem.

While our initial focus in Asia has been on its largest market in China, this is just phase one of our plans to actively seek partnerships in the Asian market. Cardiovascular disease is a problem that the entire region is struggling to cope with. In Japan for example, the number of people suffering from hypertension is increasing steadily.

Raising Additional Funds in the Asian Market

New approaches are necessary and ABS’s innovative stenting system is a prime example. Our method allows for the placement of stents in both the mother and daughter arteries of a bifurcating lesion at the same time. The procedure is simpler, less time consuming, and more affordable than anything being used today.

In the coming months, we expect to begin the application to the FDA and other regulatory bodies.  In turn, we’ll continue to seek out new partners in Asia and around the globe. Our CEO and board have set a goal of raising an additional $20 million in investment to fund this growth and feels like ABS has huge potential.

Charles Laverty’s trip to China may have started the ball rolling, but it is one more exciting stage in the growth of ABS. The next few months will be an opportunity to continue that momentum and seek out new opportunities.


  • -
Heart Health Month

ABS Executives Support Heart Health Month

Drawing Attention To A Global Crisis

Almost 18 million people will die in 2018 because of cardiovascular disease and related conditions. This is humanity’s greatest killer and it increasingly is becoming the number one killer of both genders in most places.

February is Heart Health Month. ABS’s CEO, Charles Laverty and co-founder and Chief Medical Officer, Dr. Mehran Khorsandi, want to encourage people to support our efforts to address this global issue.

A Global Problem Affecting All Groups

Advanced Bifurcation Systems hopes to be part of the solution. Mr. Laverty points out that heart disease is the number one killer of American women and cannot be considered a ‘male disease.’ While Dr. Khorsandi encourages people to remember the global scale of the problem.

Join us in supporting heart healthy organizations, programs and by encouraging behaviors that will help us to reign in heart disease.


  • -

Charles Laverty Starts A Trip To China To Talk ABS

CEO Charles Laverty is Blogging About his Trip to China

Heart disease in the number one global killer and Charley is there to talk with potential partners about opportunities to work together to tackle it. He already is sharing some humorous and insightful observations about travel to China.